Current research into drug treatments for CLL - specifically ibrutinib, idelalisib and venetoclax
Do CLL patients with mutated immunoglobulin receptors respond better to therapy?
MPN Landmark studies: looking at the disparities in perceptions of disease and treatment preferences
The iwCLL 2017 meeting
Mutations found in myeloma patients